# Everett E. Vokes

Source: https://onco.cc/people/everett-vokes/  
OnCo record `everett-vokes` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Head and neck cancer leader who established organ-preserving chemoradiation and led ASCO in 2021-22.

## Summary

Everett Vokes is Chair of Medicine at the University of Chicago and served as President of the American Society of Clinical Oncology (ASCO) for 2021 to 2022. A medical oncologist specialising in head and neck and lung cancer, his trials of induction chemotherapy and chemoradiotherapy shaped head and neck cancer treatment and established organ-preserving chemoradiation. His papers include a New England Journal of Medicine review of head and neck cancer and a Journal of Clinical Oncology report on weekly carboplatin and paclitaxel followed by concomitant chemoradiotherapy as curative, organ-preserving therapy for advanced head and neck cancer. His record links to the RTOG 0129 HPV analysis and modern image-guided radiotherapy.

## Fields

- Kind: Person
- Last checked: 2026-09-08
- Role: ASCO President 2021-2022; Chair of Medicine, University of Chicago
- Specialisms: Head and neck cancer; Lung cancer; Chemoradiation

## Sources

- Wikipedia: https://en.wikipedia.org/wiki/Everett_E._Vokes
- ASCO leadership: https://www.asco.org/about-asco/asco-leadership
- PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=Vokes%20EE%5BAuthor%5D
- Google Scholar: https://scholar.google.com/scholar?q=Everett%20E.%20Vokes

## Connected records

- cancers: [Head and neck squamous cell carcinoma](https://onco.cc/cancers/head-and-neck/), [Non-small-cell lung cancer](https://onco.cc/cancers/nsclc/)
- technologies: [IMRT / IGRT (modern external beam)](https://onco.cc/technologies/imrt-igrt/)
- institutions: [American Society of Clinical Oncology (ASCO)](https://onco.cc/institutions/asco/), [University of Chicago Medicine Comprehensive Cancer Center](https://onco.cc/institutions/uchicago-cancer/)
- trials: [RTOG 0129 (HPV analysis)](https://onco.cc/trials/rtog-0129/)
- key papers: [CheckMate 816: three cycles of nivolumab plus chemotherapy before lung cancer surgery](https://onco.cc/key-papers/paper-checkmate-816-nejm-2022/)

---
JSON: https://onco.cc/api/v1/entities/everett-vokes.json